全球主动脉瓣置换装置市场规模、份额、趋势和成长分析报告（2026-2034年）

预计主动脉瓣置换装置市场将从 2025 年的 84 亿美元成长到 2034 年的 209 亿美元，2026 年至 2034 年的复合年增长率为 10.66%。

受主动脉瓣狭窄盛行率上升和全球人口老化的推动，主动脉瓣置换装置市场预计将显着增长。随着心血管疾病持续增加，高效能微创治疗方法的需求日益增长。主动脉瓣置换术，特别是经导管主动脉瓣置换术术（TAVR），因其与传统外科手术相比具有显着的临床获益并缩短恢復时间而备受关注。

瓣膜设计和输送系统的技术进步正在提高主动脉瓣置换术的安全性和有效性。生物瓣膜和创新材料的研发正在改善患者预后，并扩大可从这些手术中获益的患者范围。此外，以病人为中心的医疗模式日益受到重视，推动了对更耐用、性能更高的器械的需求，从而确保瓣膜置换术的长期成功。

此外，人们对心血管健康和早期诊断重要性的认识不断提高，也推动了主动脉瓣置换装置市场的成长。随着医疗机构更加重视心臟疾病的主动管理，对先进诊断工具和治疗方案的需求预计将会增加。远端监测和远端医疗等数位健康技术的整合也增强了患者参与度和后续护理，进一步促进了市场扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球主动脉瓣置换装置市场：依产品划分

• 市场分析、洞察与预测
• 气球膨胀类型
• 自膨胀
• 机械膨胀型
• 主动脉瓣逆流

第五章：全球主动脉瓣置换装置市场：依材料（瓣叶）划分

• 市场分析、洞察与预测
• 牛
• 猪心包

第六章：全球主动脉瓣置换装置市场：依框架材料划分

• 市场分析、洞察与预测
• 钴铬合金
• 镍钛诺
• 其他的

第七章 全球主动脉瓣置换装置市场：依最终用途划分

• 市场分析、洞察与预测
• 住院设施
• 门诊部

第八章 全球主动脉瓣置换装置市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Boston Scientific Corporation
  • Artivion, Inc
  • LivaNova PLC
  • Abbott
  • Comp7
  • Medtronic
  • Edwards Lifesciences Corporation
  • CryolifeInc
  • JenavValve TechnologyInc
  • Micro Interventional Devices
  • Braile Biomedica

The Aortic Valve Replacement Devices Market size is expected to reach USD 20.90 Billion in 2034 from USD 8.40 Billion (2025) growing at a CAGR of 10.66% during 2026-2034.

The aortic valve replacement devices market is set for substantial growth, driven by the increasing prevalence of aortic stenosis and the aging global population. As cardiovascular diseases continue to rise, the demand for effective and minimally invasive treatment options is becoming paramount. Aortic valve replacement procedures, particularly transcatheter aortic valve replacement (TAVR), are gaining traction due to their ability to provide significant clinical benefits with reduced recovery times compared to traditional surgical approaches.

Technological advancements in valve design and delivery systems are enhancing the safety and efficacy of aortic valve replacement procedures. The development of bioprosthetic valves and innovative materials is improving patient outcomes and expanding the eligibility criteria for patients who may benefit from these interventions. Additionally, the growing emphasis on patient-centered care is driving the demand for devices that offer improved durability and performance, ensuring long-term success in valve replacement.

Furthermore, the increasing awareness of cardiovascular health and the importance of early diagnosis are contributing to the growth of the aortic valve replacement devices market. As healthcare providers focus on proactive management of heart conditions, the demand for advanced diagnostic tools and treatment options is expected to rise. The integration of digital health technologies, such as remote monitoring and telemedicine, is also enhancing patient engagement and follow-up care, further supporting the market's expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Balloon-expandable
• Self-expandable
• Mechanically Expandable
• Aortic Regurgitation

By Leaflet Material

• Bovine Pericardium
• Porcine Pericardium

By Frame Material

• Cobalt-Chromium
• Nitinol
• Others

By End-Use

• Inpatient Facilities
• Outpatient Facilities

COMPANIES PROFILED

• Boston Scientific Corporation, Artivion, Inc, LivaNova PLC, Abbott, Comp7, Medtronic, Edwards Lifesciences Corporation, Cryolife, Inc, JenavValve Technology, Inc, Micro Interventional Devices, Braile Biomedica

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Balloon-expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Self-expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Mechanically Expandable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Aortic Regurgitation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY LEAFLET MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Leaflet Material
• 5.2. Bovine Pericardium Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Porcine Pericardium Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY FRAME MATERIAL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Frame Material
• 6.2. Cobalt-Chromium Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Nitinol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Inpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AORTIC VALVE REPLACEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Leaflet Material
  • 8.2.3 By Frame Material
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Leaflet Material
  • 8.3.3 By Frame Material
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Leaflet Material
  • 8.4.3 By Frame Material
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Leaflet Material
  • 8.5.3 By Frame Material
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Leaflet Material
  • 8.6.3 By Frame Material
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AORTIC VALVE REPLACEMENT DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Boston Scientific Corporation
  • 10.2.2 Artivion, Inc
  • 10.2.3 LivaNova PLC
  • 10.2.4 Abbott
  • 10.2.5 Comp7
  • 10.2.6 Medtronic
  • 10.2.7 Edwards Lifesciences Corporation
  • 10.2.8 CryolifeInc
  • 10.2.9 JenavValve TechnologyInc
  • 10.2.10 Micro Interventional Devices
  • 10.2.11 Braile Biomedica